Table 2.
Age-standardized incidence rates among men and women by quintiles of district-level socioeconomic deprivation.
| Quintiles of socioeconomic deprivation | |||||
|---|---|---|---|---|---|
| 1 (least deprived) | 2 | 3 | 4 | 5 (most deprived) | |
| SIR (95% CI) | SIR (95% CI) | SIR (95% CI) | SIR (95% CI) | SIR (95% CI) | |
| ALL CANCERS (C00–C97)a | |||||
| Men | 648.7 (635.9–661.6) | 664.9 (653.8–676.1) | 686.8 (675.8–697.8) | 691.8 (680.8–702.8) | 695.9 (683.7–708.0) |
| Women | 491.3 (480.7–501.8) | 488.5 (479.6–497.3) | 497.3 (488.6–505.9) | 489.2 (480.7–497.8) | 486.8 (477.5–496.1) |
| ORAL AND UPPER RESPIRATORY TRACT (C00–C06, C09–C14, C32) | |||||
| Men | 27.3 (25.9–28.6) | 27.8 (26.5–29.1) | 28.6 (27.3–29.9) | 32.6 (31.2–34.0) | 33.9 (32.3–35.4) |
| Women | 7.8 (7.3–8.4) | 7.8 (7.3–8.4) | 8.0 (7.5–8.5) | 7.6 (7.1–8.2) | 8.3 (7.7–8.9) |
| ESOPHAGUS (C15) | |||||
| Men | 11.9 (11.3–12.6) | 12.9 (12.2–13.6) | 13.6 (12.9–14.3) | 13.3 (12.6–13.9) | 14.2 (13.5–14.9) |
| Women | 3.1 (2.8–3.4) | 3.0 (2.7–3.2) | 3.3 (3.0–3.5) | 3.0 (2.7–3.3) | 2.8 (2.5–3.0) |
| STOMACH (C16) | |||||
| Men | 23.7 (22.8–24.7) | 24.5 (23.6–25.5) | 25.9 (24.9–26.9) | 27.4 (26.4–28.4) | 29.0 (27.9–30.0) |
| Women | 12.6 (12.0–13.1) | 13.7 (13.1–14.3) | 13.5 (13.0–14.1) | 14.0 (13.5–14.6) | 14.7 (14.1–15.3) |
| COLORECTUM (C18–C20) | |||||
| Men | 88.1 (85.5–90.7) | 92.2 (89.6–94.8) | 93.8 (91.3–96.4) | 94.3 (91.8–96.8) | 94.5 (91.9–97.1) |
| Women | 57.1 (55.3–59.0) | 58.7 (56.9–60.5) | 61.8 (60.0–63.6) | 59.4 (57.6–61.1) | 58.9 (57.1–60.7) |
| LIVER (C22) | |||||
| Men | 16.6 (15.5–17.7) | 15.6 (14.6–16.5) | 14.9 (14.0–15.8) | 16.4 (15.4–17.4) | 16.9 (15.9–17.9) |
| Women | 5.0 (4.7–5.3) | 5.2 (4.9–5.6) | 4.8 (4.5–5.2) | 5.3 (5.0–5.7) | 5.8 (5.4–6.1) |
| PANCREAS (C25) | |||||
| Men | 22.5 (21.6–23.3) | 21.2 (20.4–22.0) | 21.6 (20.8–22.4) | 22.5 (21.7–23.3) | 24.0 (23.1–24.8) |
| Women | 17.7 (17.2–18.3) | 17.4 (16.8–18.0) | 16.8 (16.3–17.4) | 17.1 (16.5–17.6) | 17.4 (16.8–18.0) |
| LUNG (C33–C34) | |||||
| Men | 77.4 (74.1–80.8) | 85.1 (81.9–88.2) | 93.1 (89.8–96.4) | 99.9 (96.4–103.3) | 103.1 (99.2–106.9) |
| Women | 35.5 (33.1–37.9) | 35.5 (33.5–37.6) | 38.8 (36.7–41.0) | 38.6 (36.4–40.7) | 37.7 (35.4–40.0) |
| MALIGNANT MELANOMA OF SKIN (C43) | |||||
| Men | 31.6 (29.8–33.4) | 30.0 (28.4–31.6) | 28.4 (26.9–29.9) | 25.0 (23.6–26.3) | 22.9 (21.6–24.2) |
| Women | 26.8 (25.0–28.7) | 24.7 (23.2–26.2) | 26.1 (24.6–27.6) | 22.4 (21.0–23.7) | 21.1 (19.6–22.5) |
| BREAST (C50) | |||||
| Women | 159.1 (154.6–163.7) | 156.7 (152.7–160.6) | 158.5 (154.6–162.3) | 152.6 (148.9–156.3) | 151.7 (147.8–155.7) |
| CERVIX UTERI (C53) | |||||
| Women | 10.9 (10.3–11.5) | 10.7 (10.1–11.3) | 11.3 (10.7–11.9) | 12.5 (11.8–13.1) | 12.1 (11.5–12.8) |
| OVARY (C56) | |||||
| Women | 17.1 (16.4–17.8) | 17.3 (16.6–18.0) | 17.6 (16.9–18.3) | 16.6 (15.9–17.3) | 15.9 (15.2–16.5) |
| PROSTATE (C61) | |||||
| Men | 168.8 (163.0–174.7) | 170.8 (165.6–175.9) | 178.8 (173.6–183.9) | 170.6 (165.8–175.5) | 173.1 (167.7–178.5) |
| KIDNEY (C64) | |||||
| Men | 23.3 (22.2–24.5) | 24.8 (23.6–26.0) | 24.6 (23.5–25.7) | 27.2 (26.0–28.4) | 28.3 (27.1–29.6) |
| Women | 11.1 (10.5–11.7) | 12.1 (11.4–12.7) | 12.1 (11.5–12.8) | 13.2 (12.6–13.9) | 14.3 (13.6–15.0) |
| BLADDER (C67) | |||||
| Men | 27.7 (26.2–29.2) | 29.4 (27.9–30.9) | 30.9 (29.4–32.4) | 31.9 (30.4–33.5) | 33.2 (31.5–34.8) |
| Women | 7.7 (7.2–8.2) | 8.0 (7.5–8.6) | 8.4 (7.9–8.9) | 8.6 (8.1–9.1) | 9.1 (8.6–9.7) |
| THYROID GLAND (C73) | |||||
| Men | 6.0 (5.5–6.5) | 5.0 (4.5–5.4) | 5.1 (4.7–5.5) | 4.0 (3.6–4.3) | 3.8 (3.5–4.2) |
| Women | 12.4 (11.4–13.4) | 11.4 (10.6–12.3) | 10.5 (9.7–11.3) | 8.4 (7.8–9.1) | 9.5 (8.7–10.2) |
| LYMPHOID AND HEMATOPOIETIC NEOPLASMS (C81–C96) | |||||
| Men | 51.3 (49.3–53.3) | 54.4 (52.4–56.4) | 54.3 (52.4–56.2) | 55.3 (53.4–57.3) | 56.3 (54.3–58.4) |
| Women | 33.7 (32.4–35.0) | 35.9 (34.6–37.3) | 36.5 (35.2–37.8) | 37.0 (35.7–38.3) | 37.6 (36.2–38.9) |
a
Without C44 and C77–C79; CI, confidence interval; SIR, standardized incidence rate; All rates are predictive margins (predicted cases per 100,000 residents) from multilevel Poisson regression models, weighted according to the 2013 European Standard Population.